882663-88-9
Chemical Structure
AMG-47a
- CAS No.: 882663-88-9
- Formula:C29H28F3N5O2
- Molecular Weight:535.56
IUPAC Name: 4-methyl-3-(2-((2-morpholinoethyl)amino)quinazolin-6-yl)-N-(3-(trifluoromethyl)phenyl)benzamide
InChIKey: DVRSTRMZTAPMKO-UHFFFAOYSA-N
SMILES: O=C(NC1=CC=CC(C(F)(F)F)=C1)C2=CC=C(C)C(C3=CC4=CN=C(NCCN5CCOCC5)N=C4C=C3)=C2
Biological Activity: AMG-47a is an orally active, ATP-competitive Lck inhibitor (IC50=0.2 nM). AMG-47a inhibits VEGF2, p38α, p38α, Jak3, MLR, and IL-2 with IC50 of 1 nM, 3 nM, 72 nM, 30 nM, and 21 nM, respectively. AMG-47a reduces T cell activation and the production of cytokines such as TGF-β, exerting anti-inflammatory and anti-fibrotic activities. AMG-47a can be used in the research of autoimmune diseases, pulmonary fibrosis, and KRAS mutation-associated cancers[1][2][3].
| Cat. No. | Product Name | Purity | Description | Pricing | |||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
|
AMG-47a | 99.19% | AMG-47a is an orally active, ATP-competitive Lck inhibitor (IC50=0.2 nM). AMG-47a inhibits VEGF2, p38α, p38α, Jak3, MLR, and IL-2 with IC50 of 1 nM, 3 nM, 72 nM, 30 nM, and 21 nM, respectively. AMG-47a reduces T cell activation and the production of cytokines such as TGF-β, exerting anti-inflammatory and anti-fibrotic activities. AMG-47a can be used in the research of autoimmune diseases, pulmonary fibrosis, and KRAS mutation-associated cancers. | ||||||||||||||||||||
|
loading...
/
|
|||||||||||||||||||||||
-
Similarity Score 0.69
HY-18849ERK2-IN-3 -
Similarity Score 0.62
HY-129348IRE1α kinase-IN-10 -
Similarity Score 0.56
HY-178042SS-3091 -
Similarity Score 0.56
HY-W721480HC-067047 hydrochloride -
Similarity Score 0.55
HY-100208RHC-067047 (Standard) -
Similarity Score 0.54
HY-153500Hedgehog IN-4 -
Similarity Score 0.54
HY-13023AMG-Tie2-1 -
Similarity Score 0.54
HY-18911Type-II-IN-1 -
Similarity Score 0.53
HY-171230MTH1 activator-1 -
Explore the MedChemAI to find more analogs
